View Item 

Show simple item record

Cancer Incidence Among Canadian Kidney Transplant Recipients

dc.contributor.authorVilleneuve, Paul J.en_US
dc.contributor.authorSchaubel, Douglas E.en_US
dc.contributor.authorFenton, Stanley S. A.en_US
dc.contributor.authorShepherd, Frances A.en_US
dc.contributor.authorJiang, Yingen_US
dc.contributor.authorMao, Y.en_US
dc.date.accessioned2010-06-01T20:44:08Z
dc.date.available2010-06-01T20:44:08Z
dc.date.issued2007-04en_US
dc.identifier.citationVilleneuve, P. J.; Schaubel, D. E.; Fenton, S. S.; Shepherd, F. A.; Jiang, Y.; Mao, Y. (2007). "Cancer Incidence Among Canadian Kidney Transplant Recipients." American Journal of Transplantation 7(4): 941-948. <http://hdl.handle.net/2027.42/73838>en_US
dc.identifier.issn1600-6135en_US
dc.identifier.issn1600-6143en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/73838
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17331115&dopt=citationen_US
dc.format.extent190579 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights2007 The Authors Journal compilation © 2007 The American Society of Transplantation and the American Society of Transplant Surgeonsen_US
dc.titleCancer Incidence Among Canadian Kidney Transplant Recipientsen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelMedicine (General)en_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Biostatistics, University of Michigan, Ann Arbor, MIen_US
dc.contributor.affiliationotherDepartment of Public Health Sciences, University of Toronto, Toronto, ON, Canadaen_US
dc.contributor.affiliationotherDivision of Nephrology, Toronto General Hospital, Toronto, Ontario, Canadaen_US
dc.contributor.affiliationotherPrincess Margaret Hospital, Toronto, Ontario, Canadaen_US
dc.contributor.affiliationotherCenter for Chronic Disease Prevention and Control, Public Health Agency of Canada, Ottawa, ON, Canadaen_US
dc.identifier.pmid17331115en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/73838/1/j.1600-6143.2007.01736.x.pdf
dc.identifier.doi10.1111/j.1600-6143.2007.01736.xen_US
dc.identifier.sourceAmerican Journal of Transplantationen_US
dc.identifier.citedreferenceSchaubel DE, Morrison HI, Desmeules M, Parsons DA, Fenton SS. End-stage renal disease in Canada: Prevalence projections to 2005. CMAJ 1999; 160: 1557 – 1563.en_US
dc.identifier.citedreferenceChauhan T. End-stage renal disease patients up nearly 19%. Cmaj 2004; 170: 1087.en_US
dc.identifier.citedreferenceParsons DA, Tracy SE, Handa KA, Greig PD. An update of the Canadian Organ Replacement Register (1998). Clin Transpl 1998; 97 – 106.en_US
dc.identifier.citedreferenceLaupacis A, Keown P, Pus N et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Int 1996; 50: 235 – 242.en_US
dc.identifier.citedreferenceWolfe RA, Ashby VB, Milford EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725 – 1730.en_US
dc.identifier.citedreferenceHampton T. Skin cancer's ranks rise: Immunosuppression to blame. JAMA 2005; 294: 1476 – 1480.en_US
dc.identifier.citedreferenceSheil AG, Disney AP, Mathew TH, Amiss N. De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation. Transplant Proc 1993; 25: 1383 – 1384.en_US
dc.identifier.citedreferenceAdami J, Gabel H, Lindelof B et al. Cancer risk following organ transplantation: A nationwide cohort study in Sweden. Br J Cancer 2003; 89: 1221 – 1227.en_US
dc.identifier.citedreferenceBrunner FP, Landais P, Selwood NH. Malignancies after renal transplantation: The EDTA-ERA registry experience. European Dialysis and Transplantation Association-European Renal Association. Nephrol Dial Transplant 1995; 10 ( Suppl 1 ): 74 – 80.en_US
dc.identifier.citedreferenceKantor AF, Hoover RN, Kinlen LJ, McMullan MR, Fraumenti JF Jr. Cancer in patients receiving long-term dialysis treatment. Am J Epidemiol 1987; 126: 370 – 376.en_US
dc.identifier.citedreferenceKyllonen L, Salmela K, Pukkala E. Cancer incidence in a kidney-transplanted population. Transpl Int 2000; 13 ( Suppl 1 ): S394 – 398.en_US
dc.identifier.citedreferencePond F, Serpell JW, Webster A. Thyroid cancer in the renal transplant population: Epidemiological study. ANZ J Surg 2005; 75: 106 – 109.en_US
dc.identifier.citedreferenceHoshida Y, Tsukuma H, Yasunaga Y et al. Cancer risk after renal transplantation in Japan. Int J Cancer 1997; 71: 517 – 520.en_US
dc.identifier.citedreferenceChapman J, Webster AC. Cancer Report: ANZDATA Registry 2004 report. Adelaide, Australia: Australia and New Zealand Dialysis and Transplant Registry; 2004.en_US
dc.identifier.citedreferenceHoover R, Fraumeni JF Jr. Risk of cancer in renal-transplant recipients. Lancet 1973; 2: 55 – 57.en_US
dc.identifier.citedreferenceKinlen LJ, Sheil AG, Peto J, Doll R. Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Br Med J 1979; 2: 1461 – 1466.en_US
dc.identifier.citedreferenceBirkeland SA, Lokkegaard H, Storm HH. Cancer risk in patients on dialysis and after renal transplantation. Lancet 2000; 355: 1886 – 1887.en_US
dc.identifier.citedreferenceBlohme I, Brynger H. Malignant disease in renal transplant patients. Transplantation 1985; 39: 23 – 25.en_US
dc.identifier.citedreferenceMoloney FJ, Comber H, O'Lorcain P, O'Kelly P, Conlon PJ, Murphy GM. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 2006; 154: 498 – 504.en_US
dc.identifier.citedreferenceChapman J, Webster AC. Chapter 10. Cancer Report. In. Cancer Report: ANZDATA Registry 2004 report. Adelaide, Australia: Australia and New Zealand Dialysis and Transplant Registry, 2004.en_US
dc.identifier.citedreferenceKyllonen L, Pukkala E, Eklund B. Cancer incidence in a kidney-transplanted population. Transpl Int 1994; 7 ( Suppl 1 ): S350 – 352.en_US
dc.identifier.citedreferenceVajdic CM, McDonald SP, McCredie MR, van Leeuwen MT, Stewart JH, Law M et al. Cancer incidence before and after kidney transplantation. JAMA 2006; 296: 2823 – 2831.en_US
dc.identifier.citedreference23.  CIHI. Treatment of End-Stage Organ Failure in Canada, 2002 and 2003. Ottawa: CIHI 2005.en_US
dc.identifier.citedreferenceCopleston P, Fenton S, Kjellstrand C et al. The Canadian Organ Replacement Register. Health Rep 1994; 6: 457 – 468.en_US
dc.identifier.citedreference25.  Statistics Canada. Vital Statistics Death Database. [Internet] 2006 September 2006 [cited 2006; Available at: http://www.statcan.ca/english/sdds/3233.htm.en_US
dc.identifier.citedreferenceSchnatter AR, Acquavella JF, Thompson FS, Donaleski D, Theriault G. An analysis of death ascertainment and follow-up through statistics Canada's Mortality Data Base system. Can J Public Health 1990; 81: 60 – 65.en_US
dc.identifier.citedreferenceGoldberg MS, Carpenter M, Theriault G, Fair M. The accuracy of ascertaining vital status in a historical cohort study of synthetic textiles workers using computerized record linkage to the Canadian Mortality Data Base. Can J Public Health 1993; 84: 201 – 204.en_US
dc.identifier.citedreferenceBand PR, Gaudette LA, Hill GB et al. The Making of the Canadian Cancer Registry: Cancer Incidence in Canada and Its Regions, 1969 to 1988. Ottawa: Ministry of Supply and Services Canada. 1993.en_US
dc.identifier.citedreferenceParkin DM, Whelan SL, Ferlay J, Raymond L, Young J. Cancer Incidence in Five Continents. Lyon, France: International Agency for Research on Cancer, 1997.en_US
dc.identifier.citedreferencePreston DL, Lubin JH, Pierce DA, McConney M. EPICURE: Risk regression and Data Analysis Software. Seattle: Hirosoft International Corporation, 1996.en_US
dc.identifier.citedreferenceBreslow NE, Day NE. Statistical methods in cancer research. Volume 2 - The design and analysis of cohort studies. IARC scientific publiaction #82. Lyon: IARC 1987.en_US
dc.identifier.citedreferenceSouthern DA, Faris PD, Brant R et al. Kaplan-Meier methods yielded misleading results in competing risk scenarios. J Clin Epidemiol 2006; 59: 1110 – 1114.en_US
dc.identifier.citedreferenceGooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: New representations of old estimators. Stat Med 1999; 18: 695 – 706.en_US
dc.identifier.citedreferenceNaldi L, Fortina AB, Lovati S et al. Risk of nonmelanoma skin cancer in Italian organ transplant recipients. A registry-based study. Transplantation 2000; 70: 1479 – 1484.en_US
dc.identifier.citedreferenceSerraino D, Piselli P, Angeletti C et al. Risk of Kaposi's sarcoma and of other cancers in Italian renal transplant patients. Br J Cancer 2005; 92: 572 – 575.en_US
dc.identifier.citedreferenceRothman KJ. Moden Epidemiology. Boston: Little, Brown and Company, 1986.en_US
dc.identifier.citedreferenceBreslow NE, Day NE. Statistical Methods in Cancer Research. Volume 2: The Design and Analysis of Cohort Studies. Lyon, France: IARC, 1987.en_US
dc.identifier.citedreferencePenn I. The changing pattern of posttransplant malignancies. Transplant Proc 1991; 23: 1101 – 1103.en_US
dc.identifier.citedreferenceKasiske BL, Vazquez MA, Harmon WE et al. Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol 2000; 11 ( Suppl 15 ): S1 – S86.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1600-6143.2007.01736.x.pdf
Size:
186.1KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.